Skip to main content

Table 2 GPs TPB intentions per country and group

From: Irrational prescribing of over-the-counter (OTC) medicines in general practice: testing the feasibility of an educational intervention among physicians in five European countries

  Control group Intervention group  
Country/Measure Baseline median (Min, Max) Difference*: median (Min, Max) Baseline median (Min, Max) Difference*: median (Min, Max) P-Value
Cyprus      
GI 4.0 0.0 6.5 1.0 0.018
(3.0, 5.0) (-1.0, 0.0) (4.0, 7.0) (0.0, 2.0)
IPS1 8.0 0.0 8.00 1.00 0.419
(6.0, 9.0) (-1.0, 1.0) (5.0, 10.0) (0.00, 1.00)
IPS2 0.0 0.00 2.0 2.0 0.017
(0.0, 2.0) (-1.0, 0.0) (2.0, 7.0) (0.0, 3.0)
No. of prescribed medicines 4 (2, 7) 0 (0, 0) 4 (2, 4) 0 (0, 0) 1.000
France      
GI 4.5 0.0 4.5 0.5 0.707
(3.0, 6.0) (-3.0, 1.5) (3.0, 6.0) (-1.0, 4.0)
IPS1 7.0 1.00 6.0 -0.5 0.209
(6.0, 9.0) (-1.0, 2.0) (6.0, 7.0) (-3.0, 1.0)
IPS2 5.0 1.0 3.5 0.5 0.156
(3.0, 7.0) (0.0, 2.0) (2.0, 5.0) (-3.0, 1.0)
No. of prescribed medicines 4 (2, 9) -1 (-1, 2) 4 (2, 9) -1 (-4, 2) 0.707
Greece      
GI 3.5 0.0 4.0 1.0 0.351
(1.0, 6.0) (-3.0, 3.5) (2.5, 5.0) (-1.5, 3.5)
IPS1 5.5 0.0 6.0 1.0 0.340
(2.0, 9.0) (-3.0, 4.0) (3.0, 8.0) (0.0, 2.0)
IPS2 3.0 0.0 4.0 1.0 0.227
(0.0, 7.0) (-2.0, 2.0) (1.0, 8.0) (-1.0, 4.0)
No. of prescribed medicines 4 0 3 0 0.477
(1, 6) (-1, 1) (1, 5) (0, 0)
Malta      
GI 4.0 0.5 4.3 1.0 0.108
(2.0, 7.0) (-1.5, 1.5) (2.0, 7.0) (-1.00, 3.0)
IPS1 6.0 0.5 7.00 1.0 0.021
(3.0, 9.0) (-1.0, 3.0) (4.0, 9.0) (1.0, 4.0)
IPS2 2.0 0.0 3.0 1.0 0.154
(0.0, 9.0) (-1.0, 2.0) (0.0, 10.0) (-1.0, 6.0)
No. of prescribed medicines 3 1 3 1 0.152
(2, 4) (-1, 1) (2, 5) (0, 3)
Turkey      
GI 4.5 0.8 4.0 0.0 0.419
(2.50, 6.0) (-3.0, 2.5) (1.0, 6.0) (-4.5, 2.0)
IPS1 7.5 0.0 8.0 1.0 0.549
(6.0, 10.0) (-2.0 7.0) (0.0, 9.0) (-6.0, 4.0)
IPS2 4.5 0.5 3.0 1.0 0.804
(2.0, 9.0) (-8.0, 8.0) (0.0, 8.0) (-5.0, 7.0)
No. of prescribed medicines 4 1 4 1 0.612
(2, 6) (-1, 4) (3, 7) (0, 2)
  1. *Differences were computed for each measure by subtracting the scores after intervention from the baseline scores.